185 related articles for article (PubMed ID: 17935711)
1. Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis.
Wang H; Zhang J; Gao C; Zhu Y; Wang C; Zheng W
Eur J Pharmacol; 2007 Dec; 577(1-3):162-9. PubMed ID: 17935711
[TBL] [Abstract][Full Text] [Related]
2. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
3. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of murine allergic rhinitis by C19, a C-terminal peptide of chemokine-like factor 1 (CKLF1).
Zheng Y; Guo C; Zhang Y; Qi H; Sun Q; Xu E; Zhang Y; Ma D; Wang Y
Int Immunopharmacol; 2011 Dec; 11(12):2188-93. PubMed ID: 22001899
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of chelidonic acid on a model of allergic rhinitis.
Oh HA; Kim HM; Jeong HJ
Int Immunopharmacol; 2011 Jan; 11(1):39-45. PubMed ID: 20974310
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-aminosalicylate on allergic rhinitis model in mice.
Kuyama S; Yamamoto A; Sugiyama M; Kakuta H; Sugimoto Y
Int Immunopharmacol; 2010 Jun; 10(6):713-6. PubMed ID: 20304104
[TBL] [Abstract][Full Text] [Related]
8. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells.
Aoi N; Masuda T; Murakami D; Yajima T; Mizubuchi H; Yamada H; Kawauchi H; Yoshikai Y
J Allergy Clin Immunol; 2006 Jun; 117(6):1359-66. PubMed ID: 16750998
[TBL] [Abstract][Full Text] [Related]
9. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis.
Jung HW; Jung JK; Park YK
Int Immunopharmacol; 2013 Jun; 16(2):254-60. PubMed ID: 23643816
[TBL] [Abstract][Full Text] [Related]
11. Topical application versus intranasal instillation: a qualitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice.
Farraj AK; Harkema JR; Kaminski NE
Toxicol Sci; 2006 Jul; 92(1):321-8. PubMed ID: 16611626
[TBL] [Abstract][Full Text] [Related]
12. In vivo intranasal anti-CD23 treatment inhibits allergic responses in a murine model of allergic rhinitis.
Zhou M; Du D; Zhao K; Zheng C
J Mol Histol; 2013 Jun; 44(3):327-38. PubMed ID: 23377922
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an allergic rhinitis model in mice for the evaluation of nasal symptoms.
Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
Life Sci; 2007 Mar; 80(15):1388-94. PubMed ID: 17300813
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis.
Kim YH; Yang TY; Park CS; Ahn SH; Son BK; Kim JH; Lim DH; Jang TY
Allergy; 2012 Feb; 67(2):183-90. PubMed ID: 22050307
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of imperatorin on allergic rhinitis: imperatorin inhibits caspase-1 activity in vivo and in vitro.
Oh HA; Kim HM; Jeong HJ
J Pharmacol Exp Ther; 2011 Oct; 339(1):72-81. PubMed ID: 21730010
[TBL] [Abstract][Full Text] [Related]
16. IL-13 is essential to the late-phase response in allergic rhinitis.
Miyahara S; Miyahara N; Matsubara S; Takeda K; Koya T; Gelfand EW
J Allergy Clin Immunol; 2006 Nov; 118(5):1110-6. PubMed ID: 17088137
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexamethasone on the expression of transforming growth factor-beta in the mouse model of allergic rhinitis.
Lee SS; Won TB; Kim JW; Rhee CS; Lee CH; Hong SC; Min YG
Laryngoscope; 2007 Aug; 117(8):1323-8. PubMed ID: 17762268
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
[TBL] [Abstract][Full Text] [Related]
20. Signals through CD40 play a critical role in the pathophysiology of Schistosoma mansoni egg antigen--induced allergic rhinitis in mice.
Hattori H; Okano M; Kariya S; Nishizaki K; Satoskar AR
Am J Rhinol; 2006; 20(2):165-9. PubMed ID: 16686380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
